
    
      A randomized, double-blind, vehicle-controlled, parallel-design, multiple-site study to
      evaluate the clinical (therapeutic) effet of a generic Ketoconazole Cream 2% (Douglas
      Pharmaceuticals America Ltd) compared with the reference standard Ketoconazole Cream 2% (Teva
      Pharmaceuticals USA Inc) in subjects with a microbiologically-confirmed, clinical diagnosis
      of tinea pedis. Approximately 675 subjects, male or female, 18 years or older, will be
      enrolled.
    
  